MICROVISION, INC. MVIS
Nasdaq · XNAS · stock · Electronic Components, NEC
Chart by TradingView
3/9
Piotroski F — financial health
-31.19
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $1.2M | -$95.0M | -$17.3M | -$59.4M | $55.5M |
| 2024 | $4.7M | -$96.9M | -$2.8M | -$68.9M | $48.8M |
| 2023 | $7.3M | -$82.8M | $4.5M | -$69.0M | $95.8M |
| 2022 | $664,000 | -$53.1M | $564,000 | -$42.4M | $89.7M |
| 2021 | $2.5M | -$43.2M | $2.5M | -$31.9M | $112.8M |
| 2020 | $3.1M | -$13.6M | $1.7M | -$16.5M | $9.0M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -31.19 (distress)
- Working capital / assets 0.494
- Retained earnings / assets -9.283
- EBIT / assets -0.803
- Equity / liabilities 1.168
Source: SEC EDGAR filings · CIK 0000065770 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.